Atorvia Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Seed
  • (Upcoming)

  • Latest Deal Amount
  • $1.5M

  • Investors
  • 11

Atorvia General Information

Description

Developer of a biotechnology platform designed to address organ failure and untreatable kidney diseases. The company leverages advanced AI drug discovery tools to conduct research into functional proteomics and the pathophysiology of organ failure, resulting in the rapid advancement of proprietary treatments for currently unaddressed kidney diseases impacting millions of patients, enabling healthcare sectors and pharmaceutical partners to deliver effective interventions and improve patient outcomes and overall longevity.

Contact Information

Website
www.atorvia.co
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 7 Bayview Station Road
  • Ottawa, Ontario
  • Canada
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Drug Delivery
Vertical(s)
Big Data, Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • 7 Bayview Station Road
  • Ottawa, Ontario
  • Canada

Atorvia Timeline

20232024202520262027
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Atorvia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Seed Round 01-Jun-2027 $1.5M Upcoming Pre-Clinical Trials
11. Accelerator/Incubator 25-Nov-2025 Completed Pre-Clinical Trials
10. Accelerator/Incubator 30-Mar-2025 Completed Pre-Clinical Trials
9. Grant 05-Jan-2025 Completed Pre-Clinical Trials
8. Accelerator/Incubator 01-Jan-2024 Completed Pre-Clinical Trials
7. Angel (individual) 15-Aug-2023 Completed Pre-Clinical Trials
6. Accelerator/Incubator 01-Jan-2023 Completed Pre-Clinical Trials
5. Accelerator/Incubator 01-Jan-2023 Completed Pre-Clinical Trials
4. Accelerator/Incubator 23-Jun-2022 Completed Pre-Clinical Trials
3. Accelerator/Incubator Completed Pre-Clinical Trials
To view Atorvia’s complete valuation and funding history, request access »

Atorvia Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biotechnology platform designed to address organ failure and untreatable kidney diseases. The company lev
Drug Discovery
Ottawa, Canada
5 As of 2026

Cambridge, United Kingdom
 

Southlake, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Atorvia Competitors (12)

One of Atorvia’s 12 competitors is Cypralis, a Angel-Backed company based in Cambridge, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cypralis Angel-Backed Cambridge, United Kingdom
Renibus Therapeutics Venture Capital-Backed Southlake, TX
SeaBeLife Venture Capital-Backed Roscoff, France
ABIONYX Pharma Formerly VC-backed Balma, France
Unicycive Formerly VC-backed Los Altos, CA
You’re viewing 5 of 12 competitors. Get the full list »

Atorvia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Atorvia Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Capital BioVentures Accelerator/Incubator
Innovation Factory (Hamilton) Accelerator/Incubator
Merck Canada Corporation Minority
SheBoot Accelerator/Incubator
Creative Destruction Lab Accelerator/Incubator
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

Atorvia FAQs

  • When was Atorvia founded?

    Atorvia was founded in 2021.

  • Where is Atorvia headquartered?

    Atorvia is headquartered in Ottawa, Canada.

  • What is the size of Atorvia?

    Atorvia has 5 total employees.

  • What industry is Atorvia in?

    Atorvia’s primary industry is Drug Discovery.

  • Is Atorvia a private or public company?

    Atorvia is a Private company.

  • What is Atorvia’s current revenue?

    The current revenue for Atorvia is .

  • How much funding has Atorvia raised over time?

    Atorvia has raised $87.6K.

  • Who are Atorvia’s investors?

    Capital BioVentures, Innovation Factory (Hamilton), Merck Canada, SheBoot, and Creative Destruction Lab are 5 of 11 investors who have invested in Atorvia.

  • Who are Atorvia’s competitors?

    Cypralis, Renibus Therapeutics, SeaBeLife, ABIONYX Pharma, and Unicycive are some of the 12 competitors of Atorvia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process